Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center

8 Oct 2019

Abstract excerpt

// Noura J. Choudhury 1 , Mansooreh Eghtesad 2 , Sabah Kadri 3 , John Cursio 4 , Lauren Ritterhouse 5 , Jeremy Segal 5 , Aliya Husain 6 and Jyoti D. Patel 1 1 Department of Medicine, The University of Chicago, Chicago, Illinois, USA 2 Department of Pathology, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA 3 Department of Pathology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31645901
DOI: 10.18632/oncotarget.27212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical centerPMID 31645901Read ↗

Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Race-Associated EGFR and KRAS Mutation Profiles in Lung Adenocarcinoma.Semantic proximity Read ↗

Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.Semantic proximity Read ↗

Racial diversity of actionable mutations in non-small cell lung cancer.Semantic proximity Read ↗

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumSemantic proximity Read ↗

Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practiceSemantic proximity Read ↗

Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?Semantic proximity Read ↗

Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.Semantic proximity Read ↗

Lung adenocarcinoma biomarker incidence in Hispanic versus non-Hispanic white patients.Semantic proximity Read ↗

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.Semantic proximity Read ↗

Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.